Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09VEY
|
|||
| Drug Name |
Spirocyclic diamine urea derivative 2
|
|||
| Synonyms |
PMID26413912-Compound-47
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
JANSSEN PHARMACEUTICA NV BREITENBUCHER, Guy, J. KEITH, John, M. JONES, William, M
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H26Cl2N4O2
|
|||
| Canonical SMILES |
C1CN(CCC12CN(C2)C(=O)NC3=CC(=CN=C3)Cl)CC4=CC(=CC=C4)OC5=CC=C(C=C5)Cl
|
|||
| InChI |
1S/C26H26Cl2N4O2/c27-20-4-6-23(7-5-20)34-24-3-1-2-19(12-24)16-31-10-8-26(9-11-31)17-32(18-26)25(33)30-22-13-21(28)14-29-15-22/h1-7,12-15H,8-11,16-18H2,(H,30,33)
|
|||
| InChIKey |
UNZBUFAASDCGFU-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.